Clinical Study

Metabolic Syndrome, Hormone Levels, and Inflammation in Patients with Erectile Dysfunction

Table 3

Hormonal parameters in patients with ED and controls. No significant differences were found (mean ± SD when normally distributed, median when nonnormally distributed).

Hormonal parametersPatients with ED Controls P value

Albumin (g/dL)4.5 ± 0.24.6 ± 0.20.12
SHBG (nmol/L)38.5 ± 19.546.7 ± 28.70.24
Total testosterone (ng/mL)4.9 ± 2.25.2 ± 1.90.71
Free testosterone (ng/mL)0.09 0.080.70*
Bioavailable testosterone (ng/mL)2.3 ± 0.82.2 ± 0.60.75
FSH (mUI/mL)6.1 ± 3.64.9 ± 1.70.23
LH (mUI/mL)4.9 ± 2.73.9 ± 1.30.07
Prolactin (ng/mL)17.7 ± 4.210.7 ± 3.70.60
Progesterona (ng/mL)0.4 ± 0.20.5 ± 0.20.43
Estradiol (pg/mL)32.2 ± 12.427.6 ± 13.80.22
TSH (μUI/mL)2.7 ± 1.72.1 ± 0.90.09

*Mann-Whitney 𝑈 test was used for nonnormal variables.